Mirum Pharmaceuticals, Inc.
MIRM Healthcare Biotechnology
Mirum Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $521.3 million, up 54.7% from fiscal 2024.
- Revenue
- +39.6%
- EPS
- −1,136.8%
- Free cash flow
- −114.2%
- Total debt
- +136.4%
Quarter to September 2026, against a year earlier
Follow MIRM
Alert me
Mirum Pharmaceuticals, Inc. (MIRM) Operating margin
Mirum Pharmaceuticals, Inc.'s operating margin over the twelve months to 30 September 2026 was −133.6%, down 129.4 percentage points from fiscal 2025 (−4.25%). Over the past ten years it has ranged from −906.1% (fiscal 2021) to 0.00% (fiscal 2020); the current reading is higher than 63% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −4.25% | 21.75 |
| FY2024 | −26.0% | 32.57 |
| FY2023 | −58.6% | 111.71 |
| FY2022 | −170.3% | 735.84 |
| FY2021 | −906.1% | (906.12) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −32.2% | (8.03) |
| Jun 2026 | −24.1% | 469.64 |
| Mar 2026 | −493.8% | (490.71) |
| Dec 2025 | −3.07% | (5.03) |
| 28 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| PTCT PTC Therapeutics, Inc. compare | 12.8% |
| LGND Ligand Pharmaceuticals Incorporated compare | 9.29% |
| KOD Kodiak Sciences Inc. compare | 0.00% |
| ORKA Oruka Therapeutics, Inc. compare | 0.00% |
| IMVT Immunovant, Inc. compare | 0.00% |
| BLTE Belite Bio, Inc. Sponsored ADR compare | 0.00% |
| IONS Ionis Pharmaceuticals, Inc. compare | −68.0% |
| MIRM Mirum Pharmaceuticals, Inc. | −133.6% |
| CGON CG Oncology, Inc. compare | −4,056.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on MIRM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement